Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial

Mahmood K. Razavi; Saravanan Balamuthusamy; Angelo N. Makris; Jeffrey G. Hoggard; Leonardo O. Harduin; Prabir Roy-Chaudhury; Robert G. Jones; Andrew Wigham; Sanford Altman; Christopher Carsten; Thomas Casciani; David Dexter; Paul Gagne; Stephen Hohmann; Randy Cooper; Fernando Kafie; Lee Kirksey; Jonah Licht; Neghae Mawla; Robert Mendes; Joseph Sabat; Eric Peden; Scott Resnick; Theodore Saad; Dana Mitchell; Theodore Yuo; Ounali Jaffer; Kate Steiner; Fabio Rossi; Dheeraj Rajan; Omran Abul-Khoudoud; Stuart Harlin; Mark L. Lessne; Leonardo Harduin; Tim Rogers; Micah Watts; Yazan Khatib; Jeffrey Siegel; Robert Molnar; Dirk Hentschel; Karl A. Illig; Thiago Barroso; Douglas Cavalcanti; James Metcalfe

doi:10.1016/j.kint.2025.01.006

journal article Open Access Apr 01, 2025

Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial

Mahmood K. Razavi Saravanan Balamuthusamy Angelo N. Makris Jeffrey G. Hoggard Leonardo O. Harduin Prabir Roy-Chaudhury

Robert G. Jones

Andrew Wigham Sanford Altman Christopher Carsten Thomas Casciani David Dexter Paul Gagne Stephen Hohmann Randy Cooper Fernando Kafie Lee Kirksey Jonah Licht Neghae Mawla Robert Mendes Joseph Sabat Eric Peden Scott Resnick Theodore Saad Dana Mitchell Theodore Yuo Ounali Jaffer Kate Steiner Fabio Rossi Dheeraj Rajan Omran Abul-Khoudoud Stuart Harlin Mark L. Lessne Leonardo Harduin Tim Rogers Micah Watts Yazan Khatib Jeffrey Siegel Robert Molnar Dirk Hentschel Karl A. Illig Thiago Barroso Douglas Cavalcanti James Metcalfe

Kidney International Vol. 107 No. 4 pp. 740-750 · Elsevier BV

View at Publisher Save 10.1016/j.kint.2025.01.006

Topics

No keywords indexed for this article. Browse by subject →

References

25

[1]

Liyanage "Worldwide access to treatment for end-stage kidney disease: a systematic review" Lancet (2015) 10.1016/s0140-6736(14)61601-9

[2]

Lawson "Challenges and novel therapies for vascular access in haemodialysis" Nat Rev Nephrol (2020) 10.1038/s41581-020-0333-2

[3]

MacRae "Arteriovenous access failure, stenosis, and thrombosis" Can J Kidney Health Dis (2016) 10.1177/2054358116669126

[4]

Bountouris "A review of percutaneous transluminal angioplasty in hemodialysis fistula" Int J Vasc Med (2018)

[5]

Lookstein "Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas" N Engl J Med (2020) 10.1056/nejmoa1914617

[6]

Trerotola "Drug coated balloon angioplasty in failing AV fistulas: a randomized controlled trial" Clin J Am Soc Nephrol (2018) 10.2215/cjn.14231217

[7]

Dolmatch "AV access covered stent clinical trials: a comparative review" Endovasc Today (2019)

[8]

Dolmatch "Prospective, randomized, multicenter clinical study comparing a self-expanding covered stent to percutaneous transluminal angioplasty for treatment of upper extremity hemodialysis arteriovenous fistula stenosis" Kidney Int (2023) 10.1016/j.kint.2023.03.015

[9]

Falk "A prospective, randomized study of an expanded polytetrafluoroethylene stent graft versus balloon angioplasty for in-stent restenosis in arteriovenous grafts and fistulae: two-year results of the RESCUE study" J Vasc Interv Radiol (2016) 10.1016/j.jvir.2016.06.014

[10]

Wu "Comparison of percutaneous transluminal angioplasty with stenting for treatment of central venous stenosis or occlusion in hemodialysis patients: a systematic review and meta-analysis" Cardiovasc Intervent Radiol (2020) 10.1007/s00270-019-02383-7

[11]

Dolmatch "Evaluation of a novel spun polytetrafluoroethylene stent graft in an ovine external iliac artery model" J Vasc Interv Radiol (2020) 10.1016/j.jvir.2019.07.036

[12]

Gilbert "First clinical results of the merit WRAPSODY cell-impermeable endoprosthesis for treatment of access circuit stenosis in haemodialysis patients" Cardiovasc Intervent Radiol (2021) 10.1007/s00270-021-03001-1

[13]

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

Hector M. Garcia-Garcia, Eugene P. McFadden, Andrew Farb et al.

Circulation 2018 10.1161/circulationaha.117.029289

[14]

Haskal "Stent graft versus balloon angioplasty for failing dialysis-access grafts" N Engl J Med (2010) 10.1056/nejmoa0902045

[15]

Haskal "Prospective, randomized, concurrently-controlled study of a stent graft versus balloon angioplasty for treatment of arteriovenous access graft stenosis: 2-year results of the RENOVA study" J Vasc Interv Radiol (2016) 10.1016/j.jvir.2016.05.019

[16]

Vesely "Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts" J Vasc Surg (2016) 10.1016/j.jvs.2016.04.035

[17]

Nordyke "Costs attributable to arteriovenous fistula and arteriovenous graft placements in hemodialysis patients with Medicare coverage" Am J Nephrol (2019) 10.1159/000502507

[18]

Hall "Choice of hemodialysis access in older adults: a cost-effectiveness analysis" Clin J Am Soc Nephrol (2017) 10.2215/cjn.11631116

[19]

Leermakers "Cost-effectiveness of vascular access for haemodialysis: arteriovenous fistulas versus arteriovenous grafts" Eur J Vasc Endovasc Surg (2013) 10.1016/j.ejvs.2012.10.012

[20]

Thamer "Medicare costs associated with arteriovenous fistulas among US hemodialysis patients" Am J Kidney Dis (2018) 10.1053/j.ajkd.2018.01.034

[21]

Razdan "Cephalic arch restenosis rates in hemodialysis patients with brachiocephalic fistulae: a retrospective multicenter analysis of 3301 patients" BMC Nephrol (2022) 10.1186/s12882-022-02728-4

[22]

Quinn "Percutaneous transluminal angioplasty versus endovascular stent placement in the treatment of venous stenoses in patients undergoing hemodialysis: intermediate results" J Vasc Interv Radiol (1995) 10.1016/s1051-0443(95)71200-3

[23]

Gray "Use of Wallstents for hemodialysis access-related venous stenoses and occlusions untreatable with balloon angioplasty" Radiology (1995) 10.1148/radiology.195.2.7724770

[24]

Kariya "Peripheral stent placement in hemodialysis grafts" Cardiovasc Intervent Radiol (2009) 10.1007/s00270-009-9580-0

[25]

Lok "KDOQI clinical practice guideline for vascular access: 2019 update" Am J Kidney Dis (2020) 10.1053/j.ajkd.2019.12.001

Metrics

6

Citations

25

References

Details

Published: Apr 01, 2025
Vol/Issue: 107(4)
Pages: 740-750
License: View

Authors

M

Mahmood K. Razavi

S

Saravanan Balamuthusamy

Genentech, South San Francisco, California

Funding

Merit Medical Systems Inc

Cite This Article

Mahmood K. Razavi, Saravanan Balamuthusamy, Angelo N. Makris, et al. (2025). Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial. Kidney International, 107(4), 740-750. https://doi.org/10.1016/j.kint.2025.01.006

Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial

You May Also Like